| 000 -LEADER |
|---|
| fixed length control field |
01532cam a22002774a 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20190314093249.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
090709s2010 flua b 001 0 eng |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781420070996 (hardcover : alk. paper) |
| 041 07 - Language |
|---|
| Language code of text/sound track or separate title |
eng |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
615.19 |
| Edition number |
22 |
| Item number |
M383 |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Martin, Yvonne Connolly, |
| Dates associated with a name |
1936- |
| 9 (RLIN) |
35027 |
| 245 10 - IMMEDIATE SOURCE OF ACQUISITION NOTE |
|---|
| Title |
Quantitative drug design : |
| Remainder of title |
a critical introduction / |
| Statement of responsibility, etc |
Yvonne Connolly Martin. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
2nd ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc |
Boca Raton, FL : |
| Name of publisher, distributor, etc |
CRC Press/Taylor & Francis, |
| Date of publication, distribution, etc |
2010. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xv, 282 p. : |
| Other physical details |
ill. ; |
| Dimensions |
25 cm. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Overview of quantitative drug design -- Noncovalent interactions in biological systems -- Preparation of 3D structures of molecules for 3D QSAR -- Calculating physical properties of molecules -- Biological data -- Form of equations that relate potency and physical properties -- Statistical basis of regression and partial least-squares analysis -- Strategy for the statistical evaluation of a data set of related molecules -- Detailed examples of QSAR calculations on erythromycin esters -- Case studies -- Methods to approach other structure-activity problems. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Structure-activity relationships. |
| 9 (RLIN) |
11002 |
|
|---|
| Topical term or geographic name as entry element |
QSAR (Biochemistry) |
| 9 (RLIN) |
35028 |
|
|---|
| Topical term or geographic name as entry element |
Drugs |
| General subdivision |
Design. |
| 9 (RLIN) |
4304 |
|
|---|
| Topical term or geographic name as entry element |
Drug Design. |
| 9 (RLIN) |
4305 |
|
|---|
| Topical term or geographic name as entry element |
Biopharmaceutics. |
| 9 (RLIN) |
236 |
|
|---|
| Topical term or geographic name as entry element |
Models, Theoretical. |
| 9 (RLIN) |
24298 |
|
|---|
| Topical term or geographic name as entry element |
Quantitative Structure-Activity Relationship. |
| 9 (RLIN) |
35029 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Source of classification or shelving scheme |
|
| Item type |
Book |
